Resultados de la búsqueda 311-320 of 9425 for monoclonal antibody

  1. Hematología - Ensayos clínicos

    Monoclonal antibodies, such as obinutuzumab, may interfere with the ability ... Rituximab is a monoclonal antibody that may interfere with the ability of cancer ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    For various rare immunobullous diseases, detection of a circulating autoantibody is necessary for accurate diagnosis. ... Monoclonal antibodies, such as rituximab ...

  4. Hematología - Ensayos clínicos

    Monoclonal antibodies, such as obinutuzumab, may interfere with the ability ... Rituximab is a monoclonal antibody that may interfere with the ability of cancer ...

  5. Hematología - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...

  6. Hematología - Ensayos clínicos

    Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving acalabrutinib ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells ...

  8. Hematología - Ensayos clínicos

    Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving acalabrutinib ...

  9. Oncología (médica) - Ensayos clínicos

    Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving ...